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Patient pathways are recognized as a valuable tool 
to support standardization, comparability, quality, and 
transparency of care processes in comprehensive care 
networks. Still, existing development approaches lack 
real practical guidance as well as an integration of the 
network and patient perspectives. Therefore, a user-
centered and requirements-based approach was chosen 
to design a patient pathway development method. It 
defines a role model and procedural steps. The method’s 
innovative character lies in the development of generic 
patient pathway templates to be adapted to national, 
regional, and local conditions of specific 
comprehensive care networks. The method was 
positively assessed in terms of demonstrating its 
applicability and the fulfilment of user requirements 
with a use case from oncology care – the development 
of a colorectal cancer patient pathway template. This 
work drives the standardization of patient pathway 
development and their large-scale implementation in 
comprehensive care networks, supporting the analysis, 
design, and optimization of healthcare processes. 
 
 
1. Introduction  
 
Patient pathways are used to plan and manage the 
whole process of care for a specific patient type, 
especially for patients with complex, long-term 
conditions, by defining goals and milestones while also 
supporting mutual decision-making by the patient and 
her/his multidisciplinary care team collaborating in a 
comprehensive network of care providers [1]–[3]. 
Against the background of an increasing demand for 
integrated care delivery in a coordinated network of 
health service providers [4], [5], the concept of patient 
pathways becomes even more important. For example, 
in cancer care - with cancer being one of the most 
common and costly diseases in western countries [6] - 
patient pathways are regarded as important tools to 
improve patient information, to implement evidence-
based medical guideline recommendations as well as to 
support seamless, optimal care in a comprehensive 
network of different health service providers [7]. 
However, uniform and standardized practical support 
for the development of patient pathways is not given yet. 
There are different procedural frameworks for the 
development and implementation of pathways (e.g. [8]–
[13]), but they are rather generic and not described in 
such detail as to provide practical guidance and support 
for the users. Also, pathway development is mostly 
addressed for single health care institutions, not the 
entire care network involved in the care process of 
patients. Also, the clinical rather than the patient 
perspective is the focus so far (e.g. [1], [14]).  
To centrally support network governance, e.g. by 
national or international non-profit organizations, and to 
increase the quality of care across care networks, a 
template-based patient pathway development approach 
is called for [9]. Patient pathway templates for particular 
patient types can function as guiding blueprints for the 
development of network-specific ones by adapting them 
to national, regional, and local specifics (e.g. availability 
of technologies or national guidelines on follow-up 
timeframes). This approach would allow for better 
comparability, consistency, and increased uniformity of 
care provision across different comprehensive care 
networks [9]. Also, similar to the general advantages of 
reference models [15], an increase of safety for patients 
and health service providers, the reduction of risks and 
costs during pathway development (e.g. by shortening 
the development time), and an increase of pathway 
quality can be expected. Still, the potentials of reusable 
patient pathway templates are not exploited yet.  
Addressing these gaps and elaborating on the 
template-based patient pathway approach, this paper 
aims to provide practical guidance with a method for the 
development of patient pathways in comprehensive care 
networks. The focus is on the construction and design of 
patient pathway templates and on highlighting the 
network and patient view. Therefore, a user-centered 
and use-case-driven approach is chosen. 





The remainder of the paper is structured as follows. 
In section 2, the used methods are described. The 
requirements analysis for practical guidance of patient 
pathway development is conducted in section 3. Based 
on this and to practically guide the development of 
patient pathways, a procedural model and a role model 
for a patient pathway development method, hereafter 
abbreviated with Pa2D-method, are described in section 
4. In section 5, the method is assessed in terms of 
demonstrating its applicability and demonstrating the 
fulfillment of user requirements with an example use 
case in oncology care. The paper closes with a 
discussion and a conclusion in sections 6 and 7. 
 
2. Method  
 
For the design and testing of a patient pathway 
development method for comprehensive care networks, 
the design science paradigm was followed [16]. With 
the aim to provide a user-centered and practical method, 
we used a qualitative data collection approach by 
defining user requirements based on user stories. A user 
story is a statement written from the end user’s 
perspective [17]. It represents a short, informal 
description of a requirement in the format “As a <role> 
I want <something> so that <benefit>.” We set up a 
workshop and asked 25 people to describe user stories 
from their own or a chosen perspective, i.e. role. The 
workshop included international participants who are 
part of an international project consortium in the domain 
of cancer care. The group consisted of health care 
providers (e. g., oncologists, nurses), managers of health 
care organizations, methodologists (e. g., medical 
guideline developers), representatives of national 
authorities and international and national health 
organizations, patient representatives as well as 
researchers. The participants were given the example 
user story “As a physician in a patient pathway 
development board I want to use an agreed upon 
pathway representation format so that all colleagues in 
[comprehensive cancer care networks] can exchange 
pathways across networks”. Altogether, 33 user stories1 
were collected. They were analyzed using a qualitative 
content analysis according to Mayring [18] with a 
coding scheme derived from a previous systematic 
literature review of existing pathway methods 
conducted by the authors [9]. Therewith, we derived 
requirements for the intended patient pathway 
development method. We focused on construction- and 
design-related requirements which specify the 
development phase for patient pathways. The roles 
specified in the user stories together with the derived 
                                               
1 The full list of user stories can be provided by the authors.  
requirements were used to develop the Pa2D-method. 
We demonstrate its applicability with the development 
of a colorectal cancer patient pathway template for 
comprehensive cancer care networks. The experiences 
during the application were used to assess the method 
and to derive lessons for improvement. The 
development team of the colorectal cancer template was 
asked to answer an online questionnaire. It addressed the 
degree of fulfilling the defined requirements with the 
Pa2D-method as well as for the personal (positive and 
negative) perception of the application of the method.  
 
3. Requirements analysis 
 
The analysis of the user stories resulted in the 
identification of functional and non-functional 
requirements which cover both general procedural 
issues as well as the representation of patient pathways. 
Functional requirements describe the desired functions 
of the intended patient pathway development method. 
We identified seven functional requirements R1 to R7. 
They are described in the following. An exemplary user 
story for each requirement is given in Table 1. 
R1 - Patient pathways for comprehensive care 
networks should have uniform template character and 
provide adaptation notes for their implementation to 
particular care networks. The development method 
should produce generic patient pathway templates, i.e. 
standard pathway patterns, which are not specific for a 
particular care network but provide a framing of 
essential building blocks for each phase of care for a 
specific disease. The templates function as guidance for 
the development of network-specific patient pathways 
and provide adaptation notes for implementation, e.g. 
required/optional parts or adaptation instructions 
considering national, regional, or local conditions. 
R2 - Patient pathways should be disease-specific. 
They should be designed for a specific patient type, e.g. 
patients with a specific tumor entity, and thus describe 
in- and exclusion criteria for entering the pathway. 
R3 - Patient pathways should be developed by a 
multi-stakeholder working group. This means, they 
should be developed by a working group consisting of 
people representing the roles and organizations involved 
in care provision along the whole pathway. This should 
also include the patient perspective. 
R4 - A patient pathway development method should 
define the group processes. This includes for example 
the definition of group composition, roles, consensus 
finding, decision-, prioritization- and review processes. 
R5 - Patient pathways should be developed based on 
scientific evidence, especially medical guideline 
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recommendations. The link of the patient pathway 
content to its evidence base should be maintained. 
Therefore, patient pathways should provide concepts to 
describe the evidence level of a recommendation (e.g. 
pathway step/decision) and to link the evidence source. 
R6 - A patient pathway should sequence obligatory 
and optional steps and the relevant information along 
all phases of care in a comprehensive care network for 
the involved care providers and the patient. Relevant 
information are tasks, decisions, roles, process flows, 
time restrictions, information objects, quality aspects. 
R7 - Patient pathways should provide a patient view 
to support shared decision-making and 
individualization. They should represent steps the 
patient is directly involved in (e.g. consultation, 
consent) or has to perform him-/herself. They should 
allow for individualization to patient-specific situations, 
e.g. patient preferences or comorbidities. 
 
Table 1. Functional requirements 
No. Example user story 
R1 “As a manager I want the methodology to 
provide guidelines on the pathway development 
and identify the essential building blocks of a 
pathway so that pathways can be developed and 
adopted to the local healthcare context of the 
[comprehensive care network].” 
R2 “As a medical doctor in training I want patient 
pathways to be tumor-specific so that I can 
provide quality of care.” 
R3 “As a patient I want patient views and 
perspectives to be integrated in the [pathway 
development] process in order to integrate 
shared (informed) decision-making in patient 
pathway development.” 
R4 “As a methodologist in a [patient pathway 
development] board I want to have 
information/agreement on consensus finding 
process so that bias in [patient pathway 
development] is controlled.” 
R5 “As a methodologist in a [patient pathway 
development] board I want to have a description 
of the evidence base and the strength of 
certainty in order to get transparent and 
reproducible results.” 
R6 “As national authority I want to have a mean to 
define obligatory tasks within the pathway.” 
R7 “As a patient I want a patient pathway that I can 
understand and that helps me make decisions 
together with my doctor and my family so that I 
can be in control of what is happening and to 
check if everything is going according to my 
expectations […].” 
 
Additionally, non-functional requirements were 
identified. These specify criteria that can be used to 
evaluate the method’s performance in terms of quality 
criteria. A method to develop patient pathways for 
comprehensive care networks should be generic, easy-
to-manage (workable), inclusive, and easy-to-
understand (e.g. “As a […] network advisor I want an 
inspiring, workable, generic method for designing and 
implementing patient pathways […]”). A standardized, 
clear and easy-to-analyze representation format of 
patient pathways should be used (e.g. “As a (healthcare) 
researcher I want conceptually clear and ‘easy to 
analyze’ […] representation so that it facilitates 
efficient, transparent and reproducible research”). 
 
4. Patient pathway development method  
 
According to Brinkkemper (1996), “[a] method is an 
approach to perform a systems development project, 
based on a specific way of thinking, consisting of 
directions and rules, structured in a systematic way in 
development activities with corresponding development 
products” [19]. Patient pathways are a processual view 
of a comprehensive care network which is a socio-
technical system [20]. To systematically guide and 
support their development, the Pa2D-method is 
proposed. In the following, its role model and the 




To specify the tasks and expected qualifications of 
people applying the Pa2D-method, the involved roles are 
summarized in Table 2.  
To meet the requirement of template-based pathway 
development (see R1, sec. 3), the roles patient pathway 
template designer and patient pathway designer are 
distinguished. The former develops the template and 
prepares it for reuse whereas the latter adapts the patient 
pathway template to national, regional, or local specifics 
of a comprehensive care network. Both roles should be 
modelling experts and experienced in the application of 
process (pathway) modelling languages. The patient 
pathway template designer additionally needs to be 
familiar with reference modelling techniques, especially 
pathway templates. Depending on the organizational 
context, both roles can be assigned to one person. 
For the development of a patient pathway template, 
the knowledge input from domain experts of the specific 
health care phenomenon, e.g. a health condition or 
disease for which the patient pathway (template) shall 
be developed, is necessary. The content of the patient 
pathway template, e.g. activities, process-, information- 
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Table 2. Role model of the Pa2D-method2 
 
or resource flows, involved roles, obligatory and 
optional parts, should be provided by a team of 
representatives of different interest groups (see R3, sec. 
3). These patient pathway template stakeholders should 
involve health policy representatives (e.g. national 
authorities, health policy developers, or advisors), 
representatives of national or international health care 
organizations or associations (e.g. representatives of 
accreditation organizations or medical guideline 
development), researchers, and representatives of 
involved units of comprehensive care networks (e.g. 
network managers, quality managers, healthcare 
                                               
2 “Patient pathway” is abbreviated with PP and “comprehensive care 
network” with CCN in Tables and Figures of this article. 
professionals). To also explicitly include the patient 
perspective (see R7, sec. 3), representatives of patient 
organizations should be involved in the patient pathway 
template development. 
Patient pathway templates are applied to specific 
comprehensive care networks. The adaptation of the 
template is supported by patient pathway users, who are 
familiar with the specific characteristics of the own 
comprehensive care network. Also, they implement the 
approved patient pathway. The patient pathway users 
primarily are medical, nursing, and supportive care 
professionals. Also, administrative staff and the patient 
him-/herself are relevant representatives. Thus, patient 
pathway users are a subgroup of patient pathway 
template stakeholders and people could be assigned both 
roles at the same time. 
The quality and progress of the patient pathway 
development process should be assured and monitored 
by a method expert. This role also includes the 
responsibility for the training and guidance of the 
project team members in terms of the Pa2D-method. 
 
4.2. Procedural model 
 
A typical project flow for the development and 
implementation of template-based patient pathways in 
comprehensive care networks consists of the main 
phases as shown in Figure 1. The process consists of two 
major parts, which are first, the development of a 
generic patient pathway template for a specific disease 
(see upper part of Figure 1) and second, the template-
based development of patient pathways for a particular 
comprehensive care network by adapting the template to 
national, regional, and local context (see lower part of 
Figure 1). This distinction is in particular due to 
requirement R1 (see sec. 3). 
The project institution for template development 
comprises the establishment of the multidisciplinary 
patient pathway template development team (working 
group) [8], [10], [13], [21]. In detail, this team shall 
consist of patient pathway template designer(s), patient 
pathway template stakeholders including patient 
pathway users, and method expert(s) as described in the 
Pa2D-method’s role model in section 4.1. Also, the team 
shall be trained and educated about the development 
process [8], [13] and the consensus finding process shall 
be defined [9] (see R3 and R4, sec. 3). The project plan, 
e.g. timetables, tasks, responsibilities, and resources, 
should be set up [10], [13]. The definition of the 
addressed patient population is necessary. 
 
Task Qualification 
Patient pathway template designer 
Ensures adequate use of the 
modelling language; excerpts the 
knowledge of the domain 
experts and transfers it into the 
PP template; prepares PP 






Patient pathway designer 
Ensures the correct application 
of the PP template; adapts the PP 
template model to CCN 







Patient pathway template stakeholder 
Gives domain input for PP 
template development; reviews 
and approves PP template 




Patient pathway user 
Uses the developed, approved 
PP and implements it in the 
accounted CCN unit; supports 
with the adaptation of the PP 
template, e.g. to CCN specifics; 
participates in approving the PP 




units along the PP 
Method expert 
Is particularly familiar with 
template-based pathway design; 
leads the execution of the 
method and conducts necessary 
trainings on the method; 
recognizes and implements 
change requests to the method; 
involves in the continuous 








Figure 1. Main phases of the Pa2D-method for 
the development of generic templates and 
their adaptation in CCNs  
 
The systematic collection and review of evidence 
should use literature reviews to analyze and assess the 
current state of existing evidence for the whole 
continuum of care covered by the patient pathway [8], 
[10], [11], [21] (see R2 and R3, sec. 3). This step should 
also include a review of existing patient pathways for 
the addressed patient type in the scientific and grey 
literature, e.g. published by healthcare organizations. In 
this context, similar concepts such as care pathway, 
clinical pathway, or patient journey should be included 
in the search as well since they are often used 
synonymously [2], [9]. The collection of evidence 
should be carried out by the patient pathway template 
stakeholders and methodologically supported by the 
method expert. The collected literature and existing 
pathways are input for the following template 
construction phase.  
The patient pathway template construction is the 
core phase of the Pa2D-method and for this reason 
highlighted in yellow in Figure 1. In Table 3, the 
essential information of this phase is represented. 
 
Table 3. External view on the phase “patient 
pathway template construction” 
Attribute Description 
Objective Development of a reference PP template 
in CCNs for specific patient population 
Input Current evidence (medical guidelines, 
systematic reviews), existing pathways, 
defined target patient population 
Output Approved and agreed upon PP template 
Roles 
involved 
PP template designer(s), PP template 
stakeholders, PP users, method experts 
Customers CCNs applying the template 
 
To practically guide the patient pathway template 
construction, a more detailed procedural description is 
provided. It consists of six steps, with the steps 2 to 5 
being performed in an iterative manner (see Fig. 2). The 
scope definition (1) includes the specification of the 
phases along the continuum of care which are to be 
covered by the patient pathway template. Such phases 
are typically the network entry, prevention, diagnosis, 
treatment planning, treatment, follow-up, rehabilitation, 
supportive care, end-of-life care, and end of network 
care. The patient population as well as in- and exclusion 
criteria for patients entering the patient pathway need to 
be defined. Also, the modeling language and tool need 
to be selected [12]. The systematic literature review of 
standard languages and notations for the graphical 
modeling of patient care processes conducted by 
Mincarone et al. [22] showed, that the Business Process 
Model and Notation (BPMN) as well as the Unified 
Modeling Language (UML), especially its activity and 
use case diagrams, are well known and used approaches 
in health care practice. Domain-specific modeling 
language extensions such as BPMN4CP, a BPMN 
extension for care pathway modeling [23], could be used 
as well. Using this modeling language, the evidence 
level and evidence source can easily be represented and 
maintained within the pathway (template) model (see 
R5, sec. 3) by the patient pathway (template) designer.  
 
Figure 2. Inner view of the phase “patient 
pathway template construction” 
 
The next step is the identification of process 
candidates (2), i.e. the identification of important 
patient pathway steps (process candidates) and linking 
them to the phases of care as defined in step (1). The 
result is called the process landscape. Therefore, the 
contents of existing pathways for the addressed patient 
population – identified with the previously conducted 
literature review – should be analyzed and mapped to 
structure the patient pathway landscape. If there are 
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workshops with the domain experts and by including the 
recommendations from medical guidelines. 
After the process landscape of the patient pathway 
template is defined, the detailing of each process 
candidate (3) follows. Therefore, a standardized input 
sheet is provided with the Pa2D-method. It roots in the 
information collected for care pathway building as 
described with the 3-blackboard method by Vanhaecht 
et al. [24] but additionally includes perspectives to be 
covered in order to meet the patient pathway specific 
requirements from section 3. The sheets should be filled 
in by the involved domain experts from the working 
group and with the results of analyzing the 
recommendations of medical guidelines and the articles 
identified with the conducted review on current 
evidence. To reduce the risk of distortion of included 
studies, the level of evidence must be paid attention to 
[25]. The input sheet is filled for each process candidate 
and requires the following information: (a) process 
name, (b) patient inclusion criteria (e.g. a subgroup of 
the generally addressed patient population), (c) 
responsible/ involved units of the comprehensive care 
network, (d) resources (e.g. medical technology, 
infrastructure), (e) process inputs (e.g. information, lab 
results), (f) detailed process description (i.e. 
interventions, decisions, consultations, tasks related to 
medical, nursing, and supportive care (i.e. 
psychological, physical, emotional, practical/ 
organizational, informational, spiritual, social support 
[26]), as well as to administration and activities the 
patient is responsible for), (g) times (i.e. time 
criticalities, time recommendations, iterations), (h) 
process outputs, (i) measures/ evaluation criteria (e.g. 
quality indicators to be assessed), (j) adaptation notes 
(i.e. required and optional steps; national, regional, local 
conditions to be considered for the implementation in a 
specific comprehensive care network).  
Using the information from the filled input sheets, 
the next step is designing the patient pathway template 
model (4) by the patient pathway template designer. 
Therefore, the process landscape view is detailed by 
specifying the process candidates, their order and 
relations. This step can be supported by also including 
methods for the derivation of pathways from medical 
guideline recommendations (e.g. [27]). The template 
designer might identify information gaps, which need to 
be closed by getting feedback from the involved domain 
experts. This can happen either on short notice or during 
the following evaluation of the patient pathway template 
(5). With this step, feedback from the working group is 
collected and need for improvements of the template is 
identified. Furthermore, the template should also be 
reviewed by external domain experts, who were not 
involved in its development. As long as there is need for 
revision of the patient pathway template, the steps (2) to 
(5) are performed in development cycles, detailing the 
template in each iteration. When the patient pathway 
template is evaluated with no need for further revisions, 
it gets final approval (6) from the working group.  
After final approval, the patient pathway template 
for the specific disease should be disseminated and 
published, i.e. made available to the comprehensive care 
networks of interest. Therefore, a messaging and 
dissemination strategy needs to be developed and 
implemented [10], [11], [21]. With this regard, a 
common patient pathway template repository, provided 
and managed by a governing agency of the addressed 
comprehensive care networks or an international health 
care society, would be beneficial [9].  
An approved patient pathway template can then be 
implemented in comprehensive care networks. When a 
network decides to develop a patient pathway based on 
such template, it first needs to establish a project 
institution for pathway development. This multi-
disciplinary project team should involve the patient 
pathway users of the network, patient pathway 
designer(s), and development method expert(s) as 
described in the Pa2D-method’s role model in section 
4.1. The task of the working group is the adaptation of 
the template to the context of the comprehensive care 
network, i.e. to national, regional, and local specificities 
which are not part of the evidence base used for pathway 
template development (medical guidelines). Therefore, 
the adaptation notes specified with the template should 
be used. Reasons for adaptation could for example be 
national disease management programs or follow-up 
plans defining timeframes of a follow-up routine. The 
pathway also needs to be adapted in case of unavailable 
technologies or care professionals (e.g. the role of nurse 
specialists might differ between countries). After its 
development, the patient pathway needs to be piloted, 
implemented and continuously evaluated in the 
comprehensive care network (see [9] for a detailed list 
of steps necessary for this purpose, e.g. checking for 
new evidence).  
 
5. Demonstration and assessment  
 
For the evaluation of the Pa2D-method, focusing on 
the template construction phase, we first, demonstrate 
its applicability using the example use case of integrated 
cancer care in section 5.1 and second, assess the Pa2D-
method in section 5.2.  
 
5.1. Demonstration - the oncology use case 
 
The Pa2D-method was tested by applying it in the 
context the large-scale European Joint Action iPAAC 
(Innovative Partnership for Action Against Cancer) 
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aiming to develop innovative approaches to advances in 
cancer control. One focus is to improve the governance 
of integrated cancer care, e.g. by the development and 
implementation of patient pathways in comprehensive 
cancer care networks (CCCNs). “A CCCN consists of 
multiple units belonging to different institutions 
dedicated to research, prevention, diagnosis, treatment, 
follow-up, supportive and palliative care and 
rehabilitation for the benefit of cancer patients and 
cancer survivors” [7]. 
The Pa2D-method was applied to develop a 
colorectal cancer patient pathway template for CCCNs 
in Europe. The working group for the development of 
the template comprised all three roles as specified in 
section 4.2. The patient pathway template stakeholders 
built an interdisciplinary and international group of 
experts in the colorectal cancer domain. The group 
comprised people from national and international health 
authorities and societies, national care providers 
(medical and nursing care) from different CCCN units, 
as well as representatives from a European colorectal 
cancer patient organization. Therewith, the stakeholders 
also included a subgroup of future patient pathway 
users. The roles of the patient pathway template 
designers and the method experts were taken by the 
authors and colleagues, i.e. information systems experts.  
In a systematic review process, existing colorectal 
cancer pathways and the evidence base (esp. medical 
guidelines such as ESMO3 clinical practice guidelines) 
for colorectal cancer care were identified. Additionally, 
pathways used in the countries and cancer centers of the 
working group members were collected. 
For the main phase of the patient pathway template 
construction (as described in Figure 2), the scope of the 
pathway template was defined. It should cover all 
phases of CCCN care for patients with a suspicion of 
colorectal cancer and for patients with a histologically 
confirmed diagnosis. Screening recommendations and 
activities of primary prevention should not be 
integrated. The scope definition also included the 
decision to use BPMN and its domain-specific 
extensions [23] for pathway template modeling. With 
this, also quality indicators can be added along the 
patient pathway. The working progress was organized 
remotely for most of the time, having physical meetings 
in-between with the whole or part of the working group. 
In the next step, the important steps of the patient 
pathway template - the process candidates - were 
identified and the process landscape was defined (see 
Figure 3). It maps the important processes to the 
different phases of colorectal cancer care in a CCCN but 
does not describe relationships between them. 
 
                                               
3 ESMO: European Society for Medical Oncology 
 
Figure 3. Process landscape defined for CCCN 
care for colorectal cancer patients (excerpt) 
 
For each process, the input sheets were filled in by the 
domain experts of the working group and based on the 
current evidence as identified with the evidence review 
process. This information was then used to detail the 
single processes if necessary and to develop a process 
model of the patient pathway template using a BPMN.io 
modeling environment adapted to patient pathway 
specific requirements [23], [28] as presented in Figure 
4. Quality indicators were included as blue circles and 
adaptation notes as comments to the corresponding 
pathway concepts. The working group regarded 
comments as sufficient, practical solution for the 
purpose of adaptation notes. A draft of the template was 
continuously reviewed by the members of the working 
group as well as by external domain experts not 
involved in the development process with background 
in medical guideline development for the addressed 
tumor entity until no further revisions were necessary. 
Then, the template was finally approved. It will be 
implemented in two pilot CCCNs in Germany and 
Poland. The implementation and adaptation process will 
be evaluated and changes to the method might be 
necessary. After this, the template will function as 
recommended patient pathway for colorectal cancer 
patients in European CCCNs. 
 
5.2. Assessment of the Pa2D-method 
 
After the demonstration of the Pa2D-method’s 
feasibility by using the colorectal cancer use case in 
section 5.1, we assess its procedure and its results (the 
patient pathway template) regarding the fulfillment of 
the initially defined requirements R1 to R7 (see section 
3). Reflecting on the experiences from the application of 
the method, we argue the completeness of fulfilling each 
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results of the six completed questionnaires received 
from the working group are included in Table 4.  
In terms of meeting the initially defined 
requirements, most of them are strongly positive. The 
results regarding R4 and R5 indicate potentials for 
stronger implementation in the Pa2D-method. The group 
processes could be guided in more detail (relating to 
R4). For example, the consensus procedures could be 
pre-defined in the method or examples for how to handle 
different opinions in the working group could be given. 
In the demonstration case, this was not necessary and 
the Pa2D-method in its current version assigns the 
responsibility for defining the consensus procedure to 
the users. The results regarding R5 show that the 
inclusion of the evidence base could be improved. The 
Pa2D-method uses the existing evidence base as a major 
input and complements it with expert knowledge and 
experiences. In the demonstration case, there were no 
contradictions identified. However, it is important to 
keep in mind, that the patient pathway template contents 
should be developed based on best available evidence. 
This is not possible for all steps and phases in the 
pathway, since scientific studies and medical guidelines 
are rather available for the medical perspective. The 
specification of the nursing, supportive care or patient 
perspective is largely based on good practice 
experiences from the domain experts. 
In summary, the procedure of the Pa2D-method for 
the development of patient pathway templates was well 
accepted and rated positively. We asked the members of 
the working group for their opinion on both what they 
liked about the procedure for patient pathway template 
construction and how it could be further improved. The 
“openness to engage with patient organizations” as well 
as the “international, inter-disciplinary and multi-level 
consultations”, “compris[ing] multi-sectoral and multi-
national experience” were highly appreciated. It was 
highlighted that the Pa2D-method template development 
procedure is a “positive interactive process which 
should assist in creating a clear template for different 
countries to adapt according to their specific needs but 
which is at the same time based on evidence”. The 
process was rated “rigorous and well thought-through”. 
The template-based approach was in general well 
accepted and is expected to have a positive impact 
especially on creating a uniformly high level of quality 
care, on reducing the risks and difficulties of patient 
pathway development for comprehensive care 
networks, on improving the quality of patient pathways 
implemented in comprehensive care networks, as well 
as on improving benchmarking of comprehensive care 
networks for the same patient populations. Potentials for 
improvement of the method were stated in terms of 
increasing the number of meetings (physical or online) 
to discuss intermediate results. The transparent 
communication of the planned development procedure 
in the beginning of the project is said to be of high 
importance. “[P]iloting [the template] will show 
bottlenecks” of the method. Then, other possible 
improvements might become apparent. 
 
6. Discussion  
 
We used a user-centered and requirements-driven 
approach to design the Pa2D-method to practically 
support the development and implementation of patient  
Figure 4. Detail of the colorectal cancer patient pathway template for CCCNs 
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Table 4. Requirements-based evaluation of the 
Pa2D-method (1: strongly agree to 5: strongly 
disagree) 
No. Fulfillment Working group assessment 
R1 Separation of template 
development and its im-
plementation (template-
based development of a 
PP for specific CCN); 
template construction 
specified as main phase  
 
R2 A PP template is 
developed for a specific 
disease, specified by in- 
and exclusion criteria in 





stakeholder group is 
defined in the role 
model; covers different 
professions and know-
ledge domains of all PP 
stages and CCN units 
 
R4 The group composition 
and consensus finding 
process are defined in 
the project institution 
phase for the PP 
template development  
R5 Systematic collection of 
evidence as separate 
phase; PP template con-
struction uses current 
evidence base; recom-
mended modeling lan-
guages provide concepts 
for representation of 
evidence in PP models 
 
R6 Obligatory and optional 
concepts are defined 
with annotations in the 
PP template model; 
adaptation notes are 
described  
R7 Patient representatives 
are explicitly included 
as PP template 
stakeholders; a patient 
view with specific tasks 
is included in the PP 
template (BPMN lane) 
 
pathways in comprehensive care networks. The method 
pathways in comprehensive care networks. The method 
provides the description of roles to be involved and 
describes a template-based patient pathway 
development procedure. The method was assessed by 
demonstrating its applicability with the use case of 
oncology care. A patient pathway template for 
colorectal cancer was developed by in international, 
interdisciplinary multi-stakeholder working group, who 
positively assessed the method based on their 
experiences with the development process. 
Critically reflecting on the limitations of our 
approach, the requirements used for the method 
development might not be complete. Further 
requirements might lead to changes in the Pa2D-method 
design. However, the requirements are supported by the 
findings of a former literature review on the topic of 
methodological support for patient pathway 
development in [9]. Also, the Pa2D-method fits into the 
existing literature on methodological support for the 
development and implementation of pathways in 
healthcare. It includes, combines and especially details 
the necessary steps described in other literature (e.g. 
referring to [8], [10]–[13]). Reflecting on the application 
and evaluation of the Pa2D-method, it needs to be 
applied for more cases than the one we demonstrated in 
section 5. It is currently also applied for the 
development of a pancreatic cancer patient pathway 
template but should also be used and tested outside of 
the oncology care domain in the future. Also, the 
implementation and adaptation of the template in 
specific comprehensive care networks will be necessary 
to demonstrate and evaluate the method in a more 
comprehensive manner. This will be conducted with 
both the colorectal and pancreatic patient pathway 
template in pilot CCCNs in Germany and Poland. A 
long-term evaluation of implemented patient pathways 
is desirable as well. Currently, the evaluation of 
pathways and their impact is rather on outcomes such as 
time, resources and costs [29]. With the patient pathway 
approach, rather patient- and network-centered 
evaluation approaches are needed - including outcome 
measures concerning patient and disease progression 
(e.g. disease management, quality of life, patient 
empowerment), coordination, or communication, which 




With the Pa2D-method, we provide practical 
guidance for the development and implementation of 
patient pathways in comprehensive care networks. 
Designing the method, a user-driven and requirements-
based procedure was followed. The template-based 
approach for patient pathway development aims to 
support uniformly high quality for comprehensive care 
5
1
0 0 0 0




0 0 0 0
1 2 3 4 5 NA
R2
6
0 0 0 0 0















0 0 0 0
1 2 3 4 5 NA
R6
3 3
0 0 0 0
1 2 3 4 5 NA
R7
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networks and to simplify and standardize the 
development process. The Pa2D-method was already 
tested in the field of oncology care by developing a 
patient pathway template for colorectal cancer care in 
CCCNs. A template for pancreatic cancer is under 
development. After implementing the templates in two 
European pilot CCCNs and thus, further testing and 
potentially improving the method itself, the Pa2D-
method will become part of the certification program in 
European cancer care. This underlines its high 
innovation and dissemination potentials. The work 
pushes standardized patient pathway development and 
the large-scale implementation in comprehensive care 
networks – thus, supporting the implementation of 
integrated care. The Pa2D-method can increase the 
usage of patient pathways in care practice and serve as 
basis for their evaluation. 
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